Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation

AAPS PharmSciTech

Volumn 10, Issue 4, 2009, Pages 1388-1395

  Sander, Camilla ^a,b   Holm, Per ^a  

^a LifeCycle Pharma   (Denmark)

^b Universitetsparken 2   (Denmark)

Author keywords

Cyclosporine; Drug carrier; Liquid loadable tablets; SMEDDS

Indexed keywords

CYCLOSPORIN A; DRUG CARRIER; MAGNESIUM ALUMINOMETASILICATE; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; COMPRESSION; CONTROLLED STUDY; DISPERSION; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; POROSITY; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; TABLET DISINTEGRATION TIME; TABLET HARDNESS; TABLET MANUFACTURE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ALUMINUM SILICATES; ANIMALS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CYCLOSPORINE; DOGS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; IMMUNOSUPPRESSIVE AGENTS; MAGNESIUM; MALE; POROSITY; TABLETS;

EID: 75549090471     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9340-0     Document Type: Article

References (21)

1. ET Cole D Cade H Benameur 2008 Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration Adv Drug Deliv Rev 60 747 756 10.1016/j.addr.2007.09.009 1:CAS:528:DC%2BD1cXitVOmsrs%3D 18096270
2. Bergstrom DH, Waranis RP, Rahman MS. Capsules, soft. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. 2nd ed. New York: Marcel Dekker; 2002. p. 317-27.
3. Marchaud D, Hughes S. Solid dosage forms from self-emulsifying lipidic formulations. Pharmaceutical Technology Europe 2008;46-9
4. CJ Porter NL Trevaskis WN Charman 2007 Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat Rev Drug Discov 6 3 231 248 10.1038/nrd2197 1:CAS:528:DC%2BD2sXit12rsbY%3D 17330072 (Pubitemid 46344627)
5. CW Pouton 2006 Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur J Pharm Sci 29 3-4 278 287 10.1016/j.ejps.2006.04.016 1:CAS:528:DC%2BD28XhtFentrrM 16815001 (Pubitemid 44740131)
6. T Yi J Wan H Xu X Yang 2008 A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs Eur J Pharm Biopharm 70 2 439 444 10.1016/j.ejpb.2008.05.001 1:CAS:528:DC%2BD1cXhtFOmtbjN 18603415
7. P Patil P Joshi A Paradkar 2004 Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen AAPS PharmSciTech 5 3 e42 10.1208/pt050342 15760075
8. RP Dixit MS Nagarsenker 2008 Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation Eur J Pharm Sci 35 3 183 192 10.1016/j.ejps.2008.06.013 1:CAS:528:DC%2BD1cXhtVyltrzJ 18652892
9. S Nazzal M Nutan A Palamakula R Shah AA Zaghloul MA Khan 2002 Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients Int J Pharm 240 1-2 103 114 10.1016/S0378-5173(02)00130-8 1:CAS:528:DC%2BD38Xktlaru7s%3D 12062506 (Pubitemid 34607707)
10. V Jannin J Musakhanian D Marchaud 2008 Approaches for the development of solid and semi-solid lipid-based formulations Adv Drug Deliv Rev 60 6 734 746 10.1016/j.addr.2007.09.006 1:CAS:528:DC%2BD1cXitVOmsro%3D 18045728 (Pubitemid 351215578)
11. T Bansal G Mustafa ZI Khan FJ Ahmad RK Khar S Talegaonkar 2008 Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs Crit Rev Ther Drug Carrier Syst 25 1 63 116 1:CAS:528:DC%2BD1cXmtFKks78%3D 18540836
12. T Ruhland SD Nielsen P Holm CH Christensen 2007 Nanoporous magnesium aluminometasilicate tablets for precise, controlled, and continuous dosing of chemical reagents and catalysts: applications in parallel solution-phase synthesis J Comb Chem 9 2 301 305 10.1021/cc060089q 1:CAS:528: DC%2BD2sXnt1Kqsg%3D%3D 17348735
13. JL Italia V Bhardwaj MN Kumar 2006 Disease, destination, dose and delivery aspects of ciclosporin: the state of the art Drug Discov Today 11 17-18 846 854 10.1016/j.drudis.2006.07.015 1:CAS:528:DC%2BD28XoslOgtLk%3D 16935754 (Pubitemid 44280030)
14. S Khoo AJ Humberstone CJH Porter GA Edvards WN Charman 1998 Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine Int J Pharm 167 155 164 10.1016/S0378-5173(98)00054-4 1:CAS:528:DyaK1cXksF2mu7s%3D (Pubitemid 28341517)
15. Montgomery DC. Design and analysis of experiments. 6th ed. Hoboken: Wiley; 2005.
16. E Washburn 1921 The dynamics of capillary flow Phys Rev 17 273 283 10.1103/PhysRev.17.273
17. Aker E. A simulation model for two-phase flow in porous media, University of Oslo, Department of Physics; 1996
18. Rowe RC, Sheskey PJ, Owen SC. crospovidone. In: Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of Pharmaceutical Excipients. 5th ed. London: Pharmaceutical Press and APhA; 2006. p. 214-6.
19. JM Odeberg P Kaufmann KG Kroon P Hoglund 2003 Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine Eur J Pharm Sci 20 4-5 375 382 10.1016/j.ejps.2003.08. 005 1:CAS:528:DC%2BD3sXptlynuro%3D 14659481 (Pubitemid 37491431)
20. Muller RH, Runge SA, Ravelli V, Thunemann AF, Mehnert W, Souto EB. Cyclosporine-loaded solid lipid nanoparticles (SLN((R))): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm. 2007. doi: 10.1016/j.ejpb.2007.07.006
21. P Patil A Paradkar 2006 Porous polystyrene beads as carriers for self-emulsifying system containing loratadine AAPS PharmSciTech 7 1 E28 10.1208/pt070128 16584159